» Articles » PMID: 38868153

Association of Auditory Charles Bonnet Syndrome with Increased Blood Flow in the Nondominant Brodmann Area 22

Overview
Journal PCN Rep
Publisher Wiley
Date 2024 Jun 13
PMID 38868153
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Auditory Charles Bonnet syndrome (aCBS) is characterized by musical hallucinations (MHs) that accompany acquired hearing impairments. This hallucination is the acoustic perception of music, sounds, or songs in the absence of an outside stimulus, and it may be associated with hyperactivity of the superior temporal lobes. Some studies have reported the possibility of improving MH with antiepileptics. To elucidate in detail the brain regions responsible for aCBS, we analyzed the regions that changed functionally after treatment.

Methods: Before and after treatment with carbamazepine (four cases), clonazepam (one case), and a hearing aid (one case), cerebral perfusion single-photon emission computed tomography (SPECT) and the Auditory Hallucination Rating Scale (AHRS) were applied to six patients with hearing-loss-associated MHs.

Results: Cerebral blood flow analysis using SPECT revealed hyperperfusion in Brodmann area (BA) 22-the posterior region of the superior temporal gyrus-in the nondominant hemisphere in all six patients in the pretreatment phase. After treatment, the hyperperfusion region improved in all patients. The area percentages with hyperperfusion in the nondominant BA22 were strongly positively correlated with the AHRS score.

Conclusion: The results suggest that aCBS, which was treatable with antiepileptics or hearing aids, was involved in hyperexcitement in BA22, and that MH strength was correlated with degree of excitement.

Citing Articles

Echoes of the Mind: Auditory Charles Bonnet Syndrome.

D N, D L, B L, C P, S H Cureus. 2024; 16(8):e66120.

PMID: 39229405 PMC: 11370646. DOI: 10.7759/cureus.66120.


Association of auditory Charles Bonnet syndrome with increased blood flow in the nondominant Brodmann area 22.

Sakimoto H, Urata Y, Ishizuka T, Kimotsuki H, Kasugai M, Fukuhara R PCN Rep. 2024; 2(2):e92.

PMID: 38868153 PMC: 11114281. DOI: 10.1002/pcn5.92.

References
1.
Ratcliff K, Farhall J, Shawyer F . Auditory hallucinations: a review of assessment tools. Clin Psychol Psychother. 2011; 18(6):524-34. DOI: 10.1002/cpp.729. View

2.
Mizumura S, Kumita S, Cho K, Ishihara M, Nakajo H, Toba M . Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med. 2003; 17(4):289-95. DOI: 10.1007/BF02988523. View

3.
Coebergh J, Lauw R, Bots R, Sommer I, Blom J . Musical hallucinations: review of treatment effects. Front Psychol. 2015; 6:814. PMC: 4468361. DOI: 10.3389/fpsyg.2015.00814. View

4.
Minoshima S, Frey K, Koeppe R, Foster N, Kuhl D . A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995; 36(7):1238-48. View

5.
Griffiths T . Musical hallucinosis in acquired deafness. Phenomenology and brain substrate. Brain. 2000; 123 ( Pt 10):2065-76. DOI: 10.1093/brain/123.10.2065. View